CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 93 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2020. The put-call ratio across all filers is 0.10 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $74,030,000 | -21.0% | 626,789 | -25.7% | 0.08% | -14.9% |
| Q3 2020 | $93,694,000 | +47.1% | 843,027 | +35.3% | 0.09% | +70.9% |
| Q2 2020 | $63,673,000 | +134.7% | 623,141 | +147.9% | 0.06% | +111.5% |
| Q1 2020 | $27,133,000 | +410.1% | 251,396 | +450.1% | 0.03% | +550.0% |
| Q4 2019 | $5,319,000 | +209.8% | 45,700 | +204.7% | 0.00% | +300.0% |
| Q3 2019 | $1,717,000 | +98.0% | 15,000 | +64.8% | 0.00% | 0.0% |
| Q2 2019 | $867,000 | -69.4% | 9,100 | -70.6% | 0.00% | -66.7% |
| Q1 2019 | $2,829,000 | +360.0% | 31,000 | +282.7% | 0.00% | +200.0% |
| Q4 2018 | $615,000 | -86.0% | 8,100 | -85.2% | 0.00% | -80.0% |
| Q3 2018 | $4,384,000 | -79.4% | 54,800 | -76.7% | 0.01% | -58.3% |
| Q2 2018 | $21,325,000 | +135.7% | 235,300 | +110.7% | 0.01% | +20.0% |
| Q1 2018 | $9,048,000 | +12.3% | 111,700 | +9.2% | 0.01% | +11.1% |
| Q4 2017 | $8,058,000 | -56.8% | 102,300 | -49.4% | 0.01% | -59.1% |
| Q3 2017 | $18,648,000 | – | 202,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|